The mitochondrial permeability transition pore (PTP) may operate as a physiological 
Summary
The mitochondrial permeability transition pore (PTP) may operate as a physiological Ca 2+ release mechanism and also contribute to mitochondrial deenergization and release of proapoptotic proteins following pathological stress, e.g., ischemia/reperfusion. Brain mitochondria exhibit unique PTP characteristics, including relative resistance to inhibition by cyclosporin A. In this study, we report that 2-aminoethoxydiphenyl borate (2-APB) blocks Ca 2+ - release (mCICR), is attributed to either activation of the PTP (3;4) or to reversal of the Ca 2+ uniporter (5) . Opening of the PTP has been implicated as a mediator of apoptotic and necrotic cell death, as well as a regulator of normal cell Ca 2+ homeostasis (4;6-12) . The characteristic traits of the PTP include reversibility (13) , sensitivity to inhibition by cyclosporin A (14) , and mitochondrial swelling associated with loss of matrix solutes (15;16) , (17) . Cyclosporin A is not always effective, however, at inhibiting Ca 2+ -induced mitochondrial swelling and loss of ∆Ψ (18) (19) (20) (21) (22) . In addition, the observation that normal intracellular concentrations of adenine nucleotides and Mg 2+ partially or completely block PTP activation (23;24) casts doubt on a physiological role of the PTP.
The extent to which mitochondria swell in response to accumulation of large Ca 2+ loads also varies considerably with experimental conditions and with mitochondrial tissue type (25) (26) (27) . Brain mitochondria are particularly resistant to Ca 2+ -induced swelling (25;28); moreover, they represent many cell populations, which may explain their heterogeneous response to large Ca 2+ loads and to inhibitors of the PTP, e.g., cyclosporin A (26), (29) .
In this study, we report that 2-APB (30) 
Experimental Procedures

Isolation of mitochondria
Non-synaptic adult rat brain mitochondria were isolated on a Percoll gradient as described previously (33) with minor modifications. Male 300-350 g Sprague-Dawley rats were used for this study. All animal procedures were carried out according to National Institutes of Health and the University of Maryland, Baltimore animal care and use committee guidelines.
Rats were sacrificed, forebrains were rapidly removed, chopped and homogenized in ice-cold isolation buffer containing 225 mM mannitol, 75 mM sucrose, 5 mM Hepes, 1 mM EGTA, with pH adjusted to 7.4 using KOH. The brain homogenate was centrifuged at 1,250 x g for 3 min;
pellet was discarded and the supernatant was centrifuged at 20,000 x g for 10 min. The pellet was resuspended in 15 % Percoll (Sigma, St Louis, MO, USA) and layered on a preformed
Percoll gradient (40 and 23 %) . Following centrifugation at 30,000 x g for 6 min, the mitochondrial fraction located at the interface of the lower two layers was removed, diluted with isolation buffer, and centrifuged at 16,600 x g for 10 min. The supernatant was discarded, and the loose pellet was resuspended in isolation buffer and centrifuged at 6,700 x g for 10 min. The resulting pellet was suspended in 100 µl of isolation medium devoid of EGTA.
Mitochondrial Ca 2+ uptake
Mitochondrial-dependent removal of medium Ca 2+ was followed using the impermeant pentapotassium salt of the ratiometric dye Fura 6F (Molecular Probes, Portland, OR, USA ] in the medium was calculated using the ratio calibration approach described by Grynkiewicz (35 State 3 (phosphorylating) respiration was initiated by the addition of mitochondria (0.5 mg/ml) to the incubation medium. State 3 respiration was terminated and State 4 (resting) respiration was initiated by the addition of 2 µM oligomycin.
Cytochrome c release from mitochondria
Aliquots of mitochondrial suspensions were taken at specified incubation times and the mitochondria separated from the suspending medium by centrifugation at 14,000 x g for 3 min.
The supernatant was carefully removed and both the supernatant and mitochondrial pellet 
NAD + + NADH release from mitochondria
Aliquots of mitochondrial suspensions were taken at specified incubation times and mitochondria were separated from the suspending medium by centrifugation at 14,000 x g for 3 min. The supernatant was carefully removed and both the supernatant and mitochondrial pellet fractions were immediately frozen and stored at -20°C. NAD + + NADH extraction from both fractions was performed according to the method described by Klingenberg (36 10 H 2 O, pH 7.8. NADH fluorescence was followed in a Hitachi F-2500 fluorescence spectrophotometer using 340 and 460 nm wavelengths for excitation and emission, respectively.
Mitochondrial swelling
Swelling of isolated mitochondria was assessed by measuring light scatter at 660 nm (40), (41) .
Results
2-APB protects against Ca
Comparison of 2-APB to cyclosporin A and bongkrekic acid.
Although cyclosporin A was effective at inhibiting the PTP in brain mitochondria in the Figure 4B ), TMRE fluorescence increased, indicating some reduction in ∆Ψ by this compound.
However, unlike what was observed in the absence of 2-APB, the subsequent addition of three pulses of Ca 2+ were followed by a return of TMRE fluorescence toward, and eventually to the level maintained before these additions. Thus at 800 sec of incubation, ∆Ψ was approaching complete depolarization in the absence of 2-APB but was at least partially retained in its presence. These observations are consistent with the onset of mCICR in the absence but not in the presence of 2-APB also observed at approximately 800 sec of incubation. It is striking that 2-APB in itself is depolarizing, however, as demonstrated that only inflicts upon the rate of Ca 2+ uptake and only after high calcium loading. It must be emphasized, that because of the Nernst equation, data from potentiometric dyes follow a logarithmic, not linear relationship (42) . The observation that is intended for demonstration on this experiment is that mitochondria depolarize further upon completion of Ca 2+ uptake ( Figure 4A ), unless they are pretreated with 2-APB ( Figure 4B ). The onset of depolarization upon high-Ca 2+ loading (~700 sec) coincides exactly with the onset of Ca 2+ release (Figure 2, curve a) . The choice of the membrane potential sensitive probe was critical. Many of the available probes were tested (safranin O, TMRM, rhodamine 123, JC-1, but they all exhibited serious drawbacks due to the necessity of high-calcium loading;
i.e. safranin O reduced maximal calcium uptake capacity considerably, as it has also been found by other laboratories (43), TMRM and rhodamine 123 were very strong respiratory inhibitors and uncouplers even at low concentrations (20 nM, not shown), affecting respiration more than TMRE -though the opposite has been observed for rat heart mitochondria (44); JC-1 gave an unsatisfactory signal-to-noise ratio, but no suppression of respiratory control (not shown).
Inhibition of Ca
2+
-induced mitochondrial cytochrome c and pyridine nucleotide release by 2-
APB.
Release of the mitochondrial intermembrane protein cytochrome c typically accompanies the osmotic swelling and rupture of the outer membrane evoked by activation of the PTP (45), (46), (47) . Loss of mitochondrial matrix pyridine nucleotides is another measure of the PTP, distinguishing it from a mechanism of depolarization mediated by activation of a "lowconductance" pore (48) . Figure 5 provides the results of ELISA determinations of cytochrome c released into the medium after the addition of Ca 2+ and a comparison of the effectiveness of 2-APB and cyclosporin A at inhibiting this release. In the absence of added Ca 2+ , less than 10% of total mitochondrial cytochrome c was lost to the suspending medium after 1800 sec of incubation. After the addition of 2400 nmol Ca 2+ mg -1 protein, approximately 58 % of total cytochrome c was released at 1800 sec. No net release was observed at 700 sec, immediately prior to when net Ca 2+ release was observed ( Figure 3 ). 2-APB but not cyclosporin A inhibited Ca 2+ -induced cytochrome c release, consistent with the differences in the effects of these drugs observed on mCICR. The same pattern was observed for release of matrix pyridine nucleotides ( Figure 6 ). The appearance of pyridine nucleotides in the medium over that observed in the absence of Ca 2+ occurred after the onset of mCICR and was inhibited by 2-APB but not cyclosporin A.
Effects of 2-APB on mitochondrial bioenergetics and relationship to inhibition of mCICR.
The effects of 2-APB on respiration by isolated non-synaptosomal brain mitochondria are described in Table 1 (Table 1 ). These results indicate that 2-APB is both a mild respiratory inhibitor and uncoupler at concentrations that protect against activation of the PTP.
The possibility that 2-APB protection against mCICR is related to its effects on respiration was tested by measuring mitochondrial Ca 2+ uptake and release in the presence of targeted respiratory inhibition. When NADH-linked respiration is completely inhibited by rotenone, active Ca 2+ uptake can still be driven by ∆Ψ established via ATP-dependent H + export catalyzed by the mitochondrial F 0 -F 1 -ATPase (49) . As shown in Figure 7A , the onset of mCICR in the presence of rotenone occurred at a smaller Ca 2+ load (800 nmol) than that required in the absence of rotenone (1200 nmol; Figure 2 ). Under this state of complete respiratory inhibition, 100 µM 2-APB still inhibited mCICR ( Figure 7A , thick vs. thin line), indicating that its moderate inhibition of O 2 consumption is unrelated to its ability to inhibit the PTP. Ca 2+ uptake was slower in the presence of 2-APB, likely due to its moderate uncoupling effect.
The possible dependence of 2-APB protection against mCICR on mitochondrial ATP hydrolysis was tested by exposing mitochondria to Ca 2+ in the absence of rotenone but in the presence of the ATPase inhibitor oligomycin. Under this condition, mCICR was also activated by 800 nmol Ca 2+ and inhibited by 2-APB ( Figure 7B ). Ca 2+ influx was significantly slower in the presence of 2-APB, as expected by the inhibition of ATPase-dependent Ca 2+ uptake (50), together with the inhibition of respiration by 100 µM 2-APB. The observations that 2-APB is effective at inhibiting mCICR in the absence and the presence of either rotenone or oligomycin indicates that its mechanism is closely related to pore opening and not due to its moderate effects on mitochondrial bioenergetics. In addition to that, moderate uncoupling could prove beneficial to a mitochondrion against noxious stimuli, lowering its ability to form free radicals at a basal level (51) . Therefore, FCCP concentration was titrated to confer the same extent of depolarization (30 nM, Figure 7C , curve a) and activation of state 4 respiration (5 nM, Figure   7C , curve b), and this range of concentration was tested as a possible protectant against PTP; under these conditions, mCICR was still present. . It therefore appears that Na + /Ca 2+ exchange activity does not contribute to the mCICR observed in these experiments and is not a target of 2-APB.
Inhibition of mitochondrial
Comparison of 2-APB with other PTP inhibitors.
Experiments identical to that described by Figure receptor blocker (59) , was also tested due to the fact that it has been proposed to resemble the active, dimerized form of 2-APB (60) (but see (61)). Due to the documented inhibitory effect of 2-APB on IP 3 receptors (30) and SERCA pump (62) , it was prudent to exclude the conception that the increase of Ca 2+ in the medium and its inhibition by 2-APB upon high-calcium loading was attributed to contaminating microsomes and/or endoplasmic reticulum. Addition of IP 3 (100 µM) or thapsigargin (2 µM) upon completion of Ca 2+ uptake did not cause any acceleration of Ca 2+ release (not shown).
Discussion
The Table 2 ). Inhibition of PTP by cyclosporin A is variable (27) , (65), pointing to the possibility of the presence of a more fundamental constituent of PTP, other than the one conferring its cyclosporin A sensitivity.
Such a constituent is exemplified by the effect of bongkrekic acid. Other than 2-APB, this compound is the only reported PTP inhibitor to block mCICR in brain mitochondria in the presence of ATP ( Figure 3 and Table 2 ). Bongkrekic acid locks the adenine nucleotide translocator at the "M" configuration. This protein has been implicated as a component of a multi-protein complex that constitutes the PTP (8). Bongkrekic acid, at concentrations required to inhibit the PTP, completely inhibits State 3 respiration due to the inhibition of the adenine nucleotide translocator. 2-APB also inhibits respiration but to a much smaller extent ( Table 1) .
As both ADP-and FCCP-stimulated respiration are affected by 2-APB, it likely affects the electron transport chain rather than adenine nucleotide transport.
Experiments were performed to determine if the effects of 2-APB on respiration and ∆Ψ are related to its PTP inhibitory activity. 2-APB inhibited mCICR in the presence of the respiratory inhibitor rotenone and in the presence of the ATP synthase inhibitor oligomycin ( Figure 7A and B, respectively). Moreover, mCICR was not inhibited by the protonophore FCCP at a concentration that mimics the respiratory uncoupling and mitochondrial membrane depolarization observed with 100 µM 2-APB ( Figure 7C ). Therefore, the moderate effects of 2-APB on respiration are unrelated to its potent inhibition of the PTP. Although moderate respiratory inhibition by 2-APB is not responsible for PTP inhibition, it probably accounts for the slightly slower rate of Ca 2+ uptake observed in the presence of 2-APB in the presence of ATP (Figures 2 and 3 ). In the absence of ATP, however, 2-APB actually accelerated the rate of mitochondrial net Ca 2+ uptake ( Figure 1B ). In the absence of ATP, even small additions of Ca 2+ induce the PTP in a significant fraction of the mitochondrial population (26) , thereby reducing the number of mitochondria capable of energy-dependent Ca 2+ accumulation. Thus, 2-APB accelerates Ca 2+ uptake in the absence of ATP by maintaining a larger population of energized mitochondria.
The PTP can assume different conductance states, including that of a "low-conductance" pore (4) , that causes membrane depolarization but not osmotic lysis unless followed by transition to a high-conductance permeability (66) . As the mCICR observed in our experiments was accompanied by release of cytochrome c and pyridine nucleotides at approximately 800 sec of incubation ( Figures 5 and 6, respectively) , the high-conductance pore was clearly activated at Release of cytochrome c can stimulate mitochondrial production reactive oxygen species (68) and loss of pyridine nucleotides and other matrix compounds, e.g., glutathione, can compromise their detoxification. Thus, 2-APB may protect against Ca 2+ -induced mitochondrial oxidative stress as well as metabolic failure. Considering the reported effects of 2-APB on TRP channels, we attempted to identify immunoreactivity of TRP family members (TRPC 1, 3, 4, 6) in highly purified mitochondrial sub-fractions (outer membrane, contact sites, inner membrane), but were unsuccessful (not shown). 2-APB may block the activation machinery of the channels participating in SOCE and not the channels themselves (80), (81) . Therefore, 2-APB-sensitive channel activating proteins similar to those involved in SOCE may be present in mitochondria in the absence of TRP channels. These proteins may interact with one or more of the many mitochondrial cation channels that have been identified electrophysiologically but not adequately characterized (82) .
In conclusion, we show that 2-APB inhibits mCICR in isolated non-synaptosomal brain mitochondria in the presence of adenine nucleotides and magnesium. Cytochrome c release (% of the total) estimated by ELISA from mitochondria incubated in the presence or absence of 2-APB or cyclosporin A and challenged by high-calcium loading. -CaCl 2: no calcium added; + CaCl 2 700 sec: 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 700 sec; + CaCl 2 1800 sec: 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec; + CaCl 2 + 2-APB 1800 sec: 100 µM 2-APB added at 50 sec, 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec; + CaCl 2 + Cys A 1800 sec: 2 µM Cys A added at 50 sec, 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec. Samples were sedimented at 14,000 g for 3 min and both supernatants and pellets were probed for cytochrome c; (*significant, p<0.05, One-way ANOVA, Dunnett's post hoc analysis, n = 4). NAD + NADH release (% of the total) estimated as described under "Experimental Procedures" from mitochondria incubated in the presence or absence of 2-APB or cyclosporin A and challenged by high-calcium loading. -CaCl 2: no calcium added; + CaCl 2 700 sec: 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 700 sec; + CaCl 2 1800 sec: 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec; + CaCl 2 + 2-APB 1800 sec: 100 µM 2-APB added at 50 sec, 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec; + CaCl 2 + Cys A 1800 sec: 2 µM Cys A added at 50 sec, 400 nmol of CaCl 2 added at 350, 500, and 600 sec, sample collected at 1800 sec. Samples were sedimented at 
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